Advertisement

Loading...

The BC Bud Corporation

BCBC.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.01(33.33%)
Canadian Market opens in 16h 38m

The BC Bud Corporation (BCBC.CN) Stock Competitors & Peer Comparison

See (BCBC.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BCBC.CNCA$0.04+33.33%5M-2.00-CA$0.02N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.61+8.40%2.8B12.97CA$0.58N/A
CURA.TOCA$3.03+14.77%2.3B-6.82-CA$0.44N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$8.90+13.09%2.1B13.25CA$0.67N/A
CRON.TOCA$3.56+4.71%1.3B-117.33-CA$0.03N/A
TRUL.CNCA$7.78+10.35%1.3B-9.66-CA$0.80N/A
TLRY.TOCA$9.30+11.38%908.2M-0.27-CA$32.71N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BCBC.CN vs CURA.CN Comparison April 2026

BCBC.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BCBC.CN stands at 5M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, BCBC.CN is priced at CA$0.04, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BCBC.CN currently has a P/E ratio of -2.00, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, BCBC.CN's ROE is -1.93%, compared to CURA.CN's ROE of -0.28%. Regarding short-term risk, BCBC.CN is more volatile compared to CURA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for BCBC.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions